Clinical Trial Update: A Study of Local Ablative Therapy (LAT) in People With Non-Small Cell Lung Cancer (NSCLC) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Local Ablative Therapy for people with non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Non-small Cell Lung Cancer, Metastatic Non Small Cell Lung Cancer | Phase 2 | Status: COMPLETED